News | June 10, 2010

Software Certified for ACC ICD Registry

June 10, 2010 – The American College of Cardiology (ACC) has certified Lumedx Corp. as an official ACC-National Cardiovascular Data Registry (NCDR) Implantable Cardioverter Defibrillator (ICD) Registry 2.0 software vendor.

Lumedx exports to the ICD registry is the latest in a suite of software applications developed to address the growing need for accessible cardiovascular data, streamlined clinical workflows and data management.

As the health care industry places more emphasis on quality measurement, transparency and evidence-based care, registry participation becomes increasingly critical. The ACC-NCDR ICD Registry collects data for implantable cardioverter defibrillator procedures. Version 2.0 has been extended to include pediatric ICD implant data, trial, ventricular, defibrillator, and left-heart lead information at time of implant, revision, replacement or surgical abandonment, and updated quality indicators.

The ICD registry module enables comprehensive data collection while simplifying the registry-participation process. The software is designed to integrate with other Apollo clinical data repository modules so it merges seamlessly with the Lumedx electrophysiology module.

For more information: www.lumedx.com/registry/index.as


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now